Back to Journals » Therapeutics and Clinical Risk Management » Volume 17
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,831 | Dovepress* | 4,270+ | 121 | 4,391 | |
PubMed Central* | 561 | 159 | 720 | ||
Totals | 4,831 | 280 | 5,111 | ||
*Since 21 October 2021 |
View citations on PubMed Central and Google Scholar